Angiotensin-converting enzyme (ACE) inhibitors improve markers of cardiovascular disease and prevent diabetes, renal disease, and cardiovascular disease.

First randomised trial ever to report that people who have a high risk of developing type 2 diabetes mellitus can prevent the disease.

New Protein Identified Which Can Possibly Unlock The Treatment For Obesity

Patients who received repaglinide/metformin treatment had lower final HbA1c values than those who received nateglinide/metformin.

New study findings indicate that replenishment of this hormone with supplements can improve endothelial function and insulin sensitivity-which may lower the risk of heart disease.

Glucosamine supplementation does not cause clinically significant changes in glucose metabolism in patients with type 2 diabetes.

Human Services Secretary Tommy Thompson wants Insurance companies to give discounts to customers who lose weight and exercise every day and the U.S. government plans to help them do it.

Metformin as adjunctive therapy for adolescents with type 1 diabetes and insulin resistance lowered hemoglobin A1c levels and decreased insulin dosage with no weight gain.

Severe gum disease may hasten death in people with diabetes, new study findings suggest.

British researchers report, that in women with gestational diabetes, a postnatal oral glucose tolerance test (OGTT) may only be necessary in women whose postnatal fasting plasma glucose is 6.0 mmol/L or more